Funding will support the company to achieve first-in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company and spinout from Oxford University, is developing a treatment for brain aneurysms, that will overcome challenges with existing medical devices. It has just raised $10m in a series A funding round. The funding […]

Press Release: Oxford, UK, 14th November 2020.   Oxford Endovascular Ltd, the developer of advanced neurovascular technologies to save lives of patients suffering from brain aneurysms has been awarded non-dilutive grant funding of £350,000 match funded by the company with £150,000 via the prestigious Smart Grant Program run by Innovate UK, the UK’s innovation agency* […]

Following extensive due diligence by medical, industry, and investor experts, Oxford Endovascular is selected as one of Europe’s top start-ups to be supported by the EIT Health Rescue Instrument.   Download the attachment:  Start-up Rescue press release FINAL 07.08.20

This kick starts the company’s next fundraise to take it to first in human clinical data. See the RESI landing page for a company update & for delegates at RESI to vote on: https://resiconference.com/digital-resi-june-2020-agenda/innovation-challenge-oxford-endovascular-ltd/

  ‘Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patient Outcomes and Healthcare Cost Savings — OXIFLOW’   This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement number 859001   Mike Karim, CEO, commented:   ‘We are delighted to have won this prestigious grant […]

Oxford Endovascular, a spin-out from Oxford University, has used ‘origami engineering for the brain’ to develop a unique, patented, next-generation flow-diverter (OxiFlow) for the minimally invasive treatment of intracranial aneurysms – a market around $1 Billion, 8% CAGR. The device has been designed by world leading Professors of Medicine & Engineering. OxiFlow, is inserted via […]

On Monday, November 12th at 1600, Oxford Endovascular appeared live on ‘The Series A Hour with Match Capital’. This second series of the fortnightly live streaming TV show from Intelligent Crowd TV is aimed at the professional investor community in the UK, Europe and Asia and provides a new and efficient way to see the […]

The company successfully raises £2.5M to continue its development work and progression through its animal studies over 2018/2019 in advance of making applications for its first in human and CE mark studies. The fundraise came from existing investors following on as well as Parkwalk, Oxford Investment Consultants, Perivoli and some private individuals investing.   Visit: https://www.eithealth.eu/-/eit-health-spain-picks-7-medtech-start-ups-to-compete-at-summit

EIT Health Spain has announced the winning start-ups who will compete in the medical technology category in the European Health Catapult Contest. The start-ups were chosen in a pitching contest. These seven finalists will join start-ups competing in the biotech and digihealth categories in a competition to determine the “best-of-the-best” during the EIT Health Summit […]

Abingdon, UK, 6 October 2017: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, are delighted to announce the winners of the prestigious OBN Awards 2017 that were presented last night in front of a sold-out audience of over 250 life science industry leaders at the Town Hall in Oxford. The Awards, which […]

OBN, the membership organisation that supports innovative life sciences companies,  today announces that Mike Karim, CEO of Oxford Endovascular is the winner of Perfect Pitch, the fast-paced, interactive and lively pitching session which was a highlight of the BioTrinity 2017 conference programme. Perfect Pitch involved ten emerging R&D companies pitch in front of a panel of seasoned […]

Oxford Endovascular Limited is a spin out from The University of Oxford. The Company is developing metallic mesh tube devices invented by engineers and clinicians at the University to treat patients suffering from brain aneurysms. OE has raised £2m from investment company Oxford Sciences Innovation PLC, the University of Oxford Innovation Fund and private investors […]

Oxford Endovascular has raised £2m from investment company Oxford Sciences Innovation PLC, Parkwalk Advisors and other private investors to take the device through clinical trials, and ultimately aims to treat thousands of patients worldwide. A brain aneurysm is a weakened point in a blood vessel where the pulsing blood pressure causes the wall of the […]